Trial intelligence / Profile preview

Hookah Smoking, Carbon Monoxide, and Coronary Endothelial Function

NCT03166787Phase 1Terminated

Sponsor
Cedars-Sinai Medical Center
Start
Aug 2017
Primary completion
Apr 2020
Countries
1
01

Overview

Phase 1, randomised, open-label trial (7 arms), sponsored by Cedars-Sinai Medical Center. Primary endpoint: Change in Myocardial Blood Flow. Started Aug 2017; status: terminated.

Beyond the preview

Go deeper on NCT03166787.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03166787.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call